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ABSTRAK
Latar belakang: transplantasi ginjal di Indonesia sedang berkembang pesat pada beberapa tahun terakhir, 
namun data mengenai karakteristik dan kesintasan transplan belum tersedia. Di Indonesia, hanya donor hidup 
yang diperbolehkan, namun pencarian donor ini seringkali sulit. Penelitian ini bertujuan untuk mendapatkan 
angka kesintasan graft dan pasien, mendeskripsikan karakteristik resipien dan donor serta proses rekrutmen 
dan evaluasi dari transplantasi ginjal di Indonesia. Metode: studi dengan desain kohort retrospektif pada semua 
donor dan resipien di RSUPN Dr. Cipto Mangunkusumo (RSCM) Januari 2011 – Mei 2017. Hanya resipien 
pada Januari 2011 hingga Mei 2014 yang diikutsertakan dalam analisis kesintasan graft dan pasien 1 dan 3 
tahun, datanya kemudian dideskripsikan menggunakan kurva Kaplan-Meier. Hasil: dari 492 data transplantasi 
ginjal didapatkan median usia donor 30 (17-66) tahun, 25,1% diantaranya terkait hubungan saudara; rerata 
usia resipien 47 ± 13.18 tahun. Sebanyak 138 resipien diteliti lebih lanjut, lalu didapatkan kesintasan 1 tahun 
death-censored graft, all-cause graft, dan pasien sebesar 92%, 82,6 %, dan 87%. Kesintasan 3 tahun death-
censored graft, all-cause graft, dan pasien sebesar 90,6%, 76,1% and 79,7%. Kurva Kaplan-Meier menunjukkan 
laju mortalitas tertinggi tampak pada bulan-bulan awal. Kesimpulan: angka kesintasan 1 tahun graft dan 
pasien adalah 92% dan 87%, sementara kesintasan 3 tahun graft dan pasien adalah 90,6% dan 79,7%. Hanya 
sebagian kecil donor yang terkait keluarga. Rekrutmen dan evaluasi donor hidup masih merupakan tantangan 
besar di Indonesia.
Kata kunci: evaluasi donor, kesintasan graft, kesintasan pasien, penyakit ginjal kronis, transplantasi organ.
ABSTRACT
Background: kidney transplantation has been developing rapidly in Indonesia in recent years, yet data on 
transplants’ characteristics and survival is still unavailable. In Indonesia, only living donors are permitted. Living 
donor are advantageous, but challenging to recruit. This study aimed to establish the graft and patient survival 
rates and to describe the characteristics of recipient and donor as well as the process of donor recruitment and 
evaluation of kidney transplantation in Indonesia. Methods: the study was a retrospective cohort on all donors 
and kidney transplant recipients at Cipto Mangunkusumo Hospital (CMH) from January 2011 to May 2017. 
Only recipients from January 2011 to May 2014 were included to establish the 1-year and 3-year graft and 
patient survival; which were described using Kaplan-Meier method. Results: data from 492 kidney transplant 
procedures were obtained (donor median age, 30 (17 – 66) years; 25.1% were family-related. Recipients mean 
age, 47 (SD 13.18 years). Data from total of 138 kidney transplant recipients were further analyzed. The 1-year 
death-censored graft survival, all-cause graft survival and patient survival were 92 %, 82.6 % and 87%. The 
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3-year death-censored graft survival, all-cause graft survival and patient survival were 90.6%, 76.1% and 79.7%. 
Kaplan-Meier’s curve showed the highest mortality rates occured in the early months. Conclusion: the 1-year 
graft and patient survival rate were 92% and 87%. The 3-year graft and patient survival rate were 90.6% and 
79.7%. Only small percentage of donor were family-related. Living donor recruitment and evaluation are still 
a big challenge in Indonesia.
Keywords: chronic kidney diseases, donor evaluation, graft survival, organ transplantation, patient survival.
INTRODUCTION
The definitive treatment for end-stage 
renal disease (ESRD) is renal replacement 
therapy, which consists of hemodialysis, 
peritoneal dialysis, and kidney transplant.1 
Kidney transplant is one of the best choices in 
renal replacement therapy because it can improve 
long-term survival and quality of life patients’ 
compared with dialysis.2
In developed countries, kidney transplant 
has become the primary choice of therapy for 
patients with ESRD.3 In the United States, in 
2013, there have been 17,600 kidney transplants.4 
In Indonesia, kidney transplantation is growing 
rapidly in these few years, particularly in 
some well-known healthcare centers such as 
Cipto Mangunkusumo Hospital (CMH). In 
the last 7 years, there have been 500 kidney 
transplantations in CMH.4
All kidney transplantations carried out in 
Indonesia were from living donors.1 It  is considered 
that living-donor kidney transplantation offers 
better result than cadaveric donor. The main 
reasons for these advantages are that living 
donors are selected carefully from healthy 
individuals and the organs are not exposed to 
haemodynamic instability, sepsis, or nephrotoxic 
agents, as are those of cadaveric donors during 
brain death. Despite some advantages of living 
donors, the number of donors, especially family 
related ones are limited and it has become a 
problem for countries which only permit living 
donors. Furthermore, the 1-year survival rate of 
post-transplant patients in various countries was 
quite high, but the survival rate decreased in the 
next several years.5 Adekoya et al2 reported that 
there was a decrease in graft survival rate from 
80.4% in the first year to 67.7% in 3 years after 
transplantation. Similar decrease also occured in 
patient survival rate. It declined from 91.9% in the 
first year to 82.1% in 3 years after transplantation. 
Hashiani et al6 conducted a study following 
transplant patients for 10 years and concluded that 
the trend of survival rate also decreased. In the 
study, the one year graft survival was 96.6% and 
decreased to 93.7% within 3 years. The number of 
survival of the graft tends to decrease at the 5th, 7th 
and 10th year, respectively to 88.9%, 87.1%, and 
85.5%.Although it was considered that graft and 
patient survival rate will decrease every year, the 
difference in the percentage of graft and patient 
survival in each country is different.
The aim of this study is to establish the 
characteristics of recipient and donor of kidney 
transplantation in CMH and the process of 
donor recruitment and evaluation of kidney 
transplantation in Indonesia. In addition, this 
study also aimed to determine the 1-year and 
3-year survival rate in CMH. This study is 
expected to be a reference to develop and improve 
the success rate of kidney transplantation in 
Indonesia through better management and 
to initiate the establishment of government 
organization for kidney transplantation.
METHODS
This was a retrospective cohort study which 
were obtained from patients’ medical record 
at Cipto Mangunkusumo Hospital from 2011 
to 2017. The subjects of this study were 492 
patients who had transplantation from 2011 to 
May 2017, with consecutive sampling technique. 
All transplantation patients aged more than 16 
years old were included.
To establish the 1-year and 3-year survival 
rate, only recipients from January 2011 to 
May 2014 were included. The precise time of 
transplant was considered as “initial event”. 
The time of irreversible rejection of transplant 
in which patient needs dialysis and/or the time 
when patients die within 1 year and 3 years were 
considered as the “end- point event”. All patients 
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who were lost to follow up were censored. 
Kaplan - Meier method were used to determine 
the survival rate. Collected data were processed 
using SPSS version 17.0, manufactured by IBM. 
The basic characteristics and clinical research 
subjects was presented in tabular form. This 
study had been approved by ethical committee 
of Faculty of Medicine, Universitas Indonesia 
and Cipto Mangunkusumo General Hospital.
RESULTS
In general ,  there were 492 kidney 
transplantation procedures performed at Cipto 
Mangunkusumo GHospital from January 2011 
to May 2017. For about 9 patients under 16 years 
and 9 patients whose data were not found in the 
medical record were excluded. For survival data 
analysis, there were 30 censored patients and 108 
patients who were observed within 3 years after 
transplantation (Figure 1).
All recipients received kidneys from living 
donors. A total of 335 recipients (70.7%) and 
317 donors (66.9%) were male. The mean age 
of transplant recipients was 47 (13.18) years old 
and the median age of donor at transplantation 
time was 30 years old (17 - 66 years).
There were 13 patients (2.7%) who had 
pre-emptive transplantation. There were 16 
patients (3.4%) who had undergone peritoneal 
dialysis before transplantation, while the rest 
had undergone hemodialysis. The most frequent 
cross-match results were 20-30% (52.1%) and 
there were 57 patients (12.0%) that have cross-
match results of >30-40%. First-degree family 
relationships with recipients (older siblings, 
siblings, parents, or children) were only found in 
119 patients (25.1%).
Graft and Patient Survival in 1 Year After 
Transplantation
Graft survival was defined as the percentage 
of the functioning graft. In the analysis, graft 
survival was divided into two definitions, 
that was death censored graft survival where 
patients who died with a functioning graft were 
Figure 1. Research subjects surveillance
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considered to have a functioning graft and all-
caused graft survival where patients who died 
with functioning graft were considered to have 
a failed graft. Patient survival was defined as the 
percentage of patients who still alive in 1 year or 
3 years after transplantation.
In the first year after transplantation, 11 of 
138 patients (8%) experienced graft failure, 
therefore the 1-year death censored graft survival 
rate was 92%. Five of them died and six patients 
were still alive within 1 year after transplantation. 
Two patients died after the first year and 4 
patients underwent hemodialysis again. In this 
study, there were 13 patients who died with a 
functioning graft, thus the all-cause graft survival 
rate was 82,6%. Furthermore, eighteen patients 
died within 1 year after transplantation, so the 
1- year patient survival rate was 87%.
Graft and Patient Survival in 3 Years After 
Transplantation
Within 3 years after transplantation, 13 of 
138 patients (9.4%) had graft failure, therefore 
the 3-year death censored graft survival rate was 
90.6%. Eight of them died within 3 years after 
transplantation. Five patients were alive until 
the end of study, four of them were required to 
undergo hemodialysis again and one patient had 
another transplantation.
In this study, there were 20 patients who 
died with a functioning graft until the third year 
after transplantation. Therefore, all-cause graft 
survival rate was 76.1%.
Twenty eight patients of 138 recipients died 
within the first 3 years, thus the 3-year patient 
survival rate was 79.7 %. Among 28 patients, 
eight were preceeded by graft failure, while 20 
(71,5%) patient’s death were caused by other 
causes (death with funtioning graft), such as 
irreversible sepsis or cardiovascular events, 
either acute myocardial infraction, pulmonary 
embolism, stroke, or cardiogenic shock.
The results of graft and patient survival both 
in the first 3 years and at the end of the study can 
be seen in Table 2.
Table 1. Characteristics of kidney transplant patients from 
January 2011 – May 2017
Characteristics (N=474) Value
Recipient age (years), mean (SD) 47 (13.18)
Donor age (years), median (range) 30 (17 – 66)
Recipient sex, n (%)
 - Male 335 (70.7)
 - Female 139 (29.3)
Donor sex, n (%)
 - Male 317 (66.9)
 - Female 157 (33.1)
Dialysis type, n (%)
 - Hemodialysis 445 (93.9)
 - Peritoneal Dialysis 16 (3.4)
 - Pre-emptive transplantation 13 (2.7)
Cross-matching, n (%)
 - 0 – 10 % 4 (0.8)
 - 10 – 20 % 69 (14.6)
 - 20 – 30 % 247 (52.1)
 - > 30 – 40 % 57 (12.0)
 - Data is not available 97 (20.5)
Recipient-donor relationship, n (%)
 - Related 119 (25.1)
 - Not related 355 (74.9)
Table 2. Graft and patient survival rate in 1 year and 3 
years after transplantation
1-year 3-year
Death censored graft survival 92.0% 90.6%
All-cause graft survival 82.6% 76.1%
Patient survival 87.0% 79.7%
Kaplan-Meier Survival Curve
The graft and patient survival rate in 1 year 
and 3 years after transplantation are illustrated 
by the Kaplan-Meier curve, as shown in the 
Figure 2.
DISCUSSION
There was a decrease in survival rate in the 
first 3 years compared to the first year, from 
92% to 90.6% for graft survival and from 87% 
to 79.7% for patient survival.1 The same pattern 
also occurred in the United States and it showed 
the same results in Indonesia. In the United States 
in 2012 the 1-year graft survival with living 
donors was 97% and the 5-year graft survival 
was 85%.4
Some researches in Asia reported various 
results, but there were similar trend of declining 
survival rates in the following years. Data from 
Thailand national registry reported that the 
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Figure 2. Kaplan-Meier curve. a: 1-year death censored graft survival; b: 3-year death censored graft survival; c: 1-year all-
cause graft survival; d: 3-year all-cause graft survival; e: 1-year patient survival, f: 3-year patient survival
1-year survival of patients with living donors 
from 2009-2013 was 99.0% and this number 
decreased in the 5-year survival to 95.8%.7 
Likewise, the 1 year graft survival with living 
donors from 2009-2013 decreased from 97.8% 
to 91.6%. From the Malaysian national registry 
until 2014, the survival of 1-year graft survival 
with living donors was 93% and decreased to 
88% in 3 years after transplantation. The decline 
also occurred in 3-year patient survival to 94% 
from 96% in the first year after transplantation.8 
A study conducted in Iran also stated that there 
was a decrease in graft survival rates from 1 
year to 3 years post transplantation (93.8% to 
86.8 %).9
Some factors that were suspected to affect 
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graft and patient survival had been studied 
previously. Factors from recipients were serum 
creatinin levels (p=0.0001), comorbidity 
(diabetes mellitus p<0.01), and surgical 
complications (RR=5.64).9-11 Otherwise, there 
were some factors from donor such as unrelated 
donor relations (P=0.0002).10 In Indonesia, 
because all donors are living donors and using 
the same immunosuppressant protocol, the 
dominant factors from recipients that may affect 
survival include comorbidity, infectious disease, 
and unrelated donors. Age and kidney function 
both on recipients and donors will certainly affect 
graft resistance and mortality. Other factors that 
should be considered are patient compliance 
after transplantation such as adherence to 
immunosuppressant drug and healthy lifestyle. 
In some circumstances, patient compliance 
may be affected by the problem of unequal drug 
availability and considerable distance between 
patient’s residence and transplant center.
This is the first study in Indonesia that 
observed the 7-year experience of kidney 
transplant in Indonesia. This study is expected 
to establish the characteristics of kidney 
transplant in Indonesia. The strength of this 
study was the study population was from the 
largest transplantation center that can represent 
the population of kidney transplant patients 
in Indonesia. This study used a total sampling 
technique so that only a few patients were 
excluded. This study has several weaknesses. 
This research did not analyze the risk factors of 
graft and patient survival. This study also did not 
analyze the cause of death in patients who died. 
It is expected in the future to do further research 
to assess the survival at a longer period of time.
CONCLUSION
The 1-year graft and patient survival rate 
were 92% and 87%. The 3-year graft and patient 
survival rate were 90.6% and 79.7%. Only small 
percentage of donor were family-related. Living 
donor recruitment and evaluation are still a big 
challenge in Indonesia.
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